Studies on Antidiabetic Activity of Atylosia Albicans in Streptozotocin-Induced Diabetic Rats

Abstract

The present study was aimed to investigate the Antidiabetic effect of Atylosia Albicans extracts in streptozotocin-induced diabetes in Wistar rats. Rats have fasted overnight, and the plant extracts at doses 100 and 200 mg/kg were administered for 14 days. Streptozotocin was used to induce diabetes mellitus. The standard hypoglycaemic agent selected for this work was Glibenclamide (10 mg/kg). The different test solutions at doses 100 and 200 mg/kg of petroleum ether, ethyl acetate and methanolic extracts respectively were given a respective group of rats. The anti-diabetic potential was assessed by determining oral glucose tolerance, fasting blood glucose, Blood glucose levels, glycated hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), high‑density lipoproteins (HDL), low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) were evaluated parameters. The methanolic extract with 200 mg/kg was more significant in anti-diabetic activity (P<0.001) on the 14th day and also significantly decreased TG, TC, VLDL‑C, LDL‑C and HbA1c (P<0.001) when compared to diabetic control rats. From the obtained results, it can be revealed that the methanolic extract of Atylosia Albicans has great potent antidiabetic activity. The results suggest that Triumfetta rotundifolia has anti-diabetic activity, thereby justifying its traditional use.